$CAH
CARDINAL HEALTH INC

2022 Q4 Form 10-Q Financial Statement

#000072137122000133 Filed on November 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $51.47B $49.60B
YoY Change 13.23% 12.82%
Cost Of Revenue $49.81B $47.99B
YoY Change 13.61% 13.38%
Gross Profit $1.663B $1.614B
YoY Change 2.91% -1.71%
Gross Profit Margin 3.23% 3.25%
Selling, General & Admin $1.191B $1.197B
YoY Change 3.48% 7.45%
% of Gross Profit 71.62% 74.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $170.0M $171.0M
YoY Change 3.66% 1.79%
% of Gross Profit 10.22% 10.59%
Operating Expenses $1.191B $1.197B
YoY Change 3.48% 7.45%
Operating Profit -$119.0M $137.0M
YoY Change -87.47% -66.99%
Interest Expense $25.00M $25.00M
YoY Change -32.43% -37.5%
% of Operating Profit 18.25%
Other Income/Expense, Net $7.000M -$2.000M
YoY Change -46.15% -150.0%
Pretax Income -$137.0M $110.0M
YoY Change -85.92% -70.19%
Income Tax -$7.000M -$1.000M
% Of Pretax Income -0.91%
Net Earnings -$130.0M $110.0M
YoY Change -365.31% -59.41%
Net Earnings / Revenue -0.25% 0.22%
Basic Earnings Per Share -$0.30 $0.41
Diluted Earnings Per Share -$498.1K $0.40
COMMON SHARES
Basic Shares Outstanding 262.1M shares 272.5M shares
Diluted Shares Outstanding 261.0M shares 273.0M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.654B $3.492B
YoY Change 15.6% 41.78%
Cash & Equivalents $3.654B $3.492B
Short-Term Investments
Other Short-Term Assets $2.258B $2.274B
YoY Change -47.96% -29.88%
Inventory $17.26B $15.89B
Prepaid Expenses
Receivables $11.42B $11.04B
Other Receivables $0.00 $0.00
Total Short-Term Assets $34.60B $32.70B
YoY Change 8.63% 9.97%
LONG-TERM ASSETS
Property, Plant & Equipment $2.341B $2.339B
YoY Change 0.86% 0.13%
Goodwill $4.986B $5.675B
YoY Change -25.09% -28.88%
Intangibles $1.632B $1.692B
YoY Change -16.01% -16.49%
Long-Term Investments
YoY Change
Other Assets $927.0M $985.0M
YoY Change 1.53% 6.95%
Total Long-Term Assets $9.886B $10.69B
YoY Change -16.45% -19.39%
TOTAL ASSETS
Total Short-Term Assets $34.60B $32.70B
Total Long-Term Assets $9.886B $10.69B
Total Assets $44.48B $43.39B
YoY Change 1.84% 0.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.08B $28.36B
YoY Change 21.5% 21.16%
Accrued Expenses $2.552B $2.619B
YoY Change -4.38% -6.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $577.0M $578.0M
YoY Change 91.69% 92.03%
Total Short-Term Liabilities $33.21B $31.56B
YoY Change 19.77% 19.1%
LONG-TERM LIABILITIES
Long-Term Debt $4.685B $4.689B
YoY Change -12.3% -12.4%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.685B $4.689B
YoY Change -12.3% -12.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.21B $31.56B
Total Long-Term Liabilities $4.685B $4.689B
Total Liabilities $46.69B $45.17B
YoY Change 9.4% 8.58%
SHAREHOLDERS EQUITY
Retained Earnings -$560.0M -$301.0M
YoY Change -144.98% -122.55%
Common Stock $2.747B $2.576B
YoY Change 0.96% -3.38%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.254B $3.880B
YoY Change 47.55% 52.34%
Treasury Stock Shares 68.00M shares 65.00M shares
Shareholders Equity -$2.213B -$1.781B
YoY Change
Total Liabilities & Shareholders Equity $44.48B $43.39B
YoY Change 1.84% 0.92%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$130.0M $110.0M
YoY Change -365.31% -59.41%
Depreciation, Depletion And Amortization $170.0M $171.0M
YoY Change 3.66% 1.79%
Cash From Operating Activities $597.0M $23.00M
YoY Change -50.04% -103.56%
INVESTING ACTIVITIES
Capital Expenditures -$85.00M $70.00M
YoY Change 14.86% 4.48%
Acquisitions
YoY Change
Other Investing Activities -$2.000M $0.00
YoY Change -107.41% -100.0%
Cash From Investing Activities -$87.00M -$70.00M
YoY Change 85.11% -108.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $7.000M
YoY Change -98.81%
Cash From Financing Activities -362.0M -$1.163B
YoY Change -18.47% -7.99%
NET CHANGE
Cash From Operating Activities 597.0M $23.00M
Cash From Investing Activities -87.00M -$70.00M
Cash From Financing Activities -362.0M -$1.163B
Net Change In Cash 148.0M -$1.225B
YoY Change -78.98% 29.77%
FREE CASH FLOW
Cash From Operating Activities $597.0M $23.00M
Capital Expenditures -$85.00M $70.00M
Free Cash Flow $682.0M -$47.00M
YoY Change -46.26% -93.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000721371
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
1-11373
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
Cardinal Health, Inc.
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-0958666
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
7000 Cardinal Place
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43017
CY2022Q3 dei City Area Code
CityAreaCode
614
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
757-5000
CY2022Q3 dei Security12b Title
Security12bTitle
Common shares (without par value)
CY2022Q3 dei Trading Symbol
TradingSymbol
CAH
CY2022Q3 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
262134053 shares
CY2022Q3 us-gaap Revenues
Revenues
49603000000 usd
CY2021Q3 us-gaap Revenues
Revenues
43968000000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
47989000000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42326000000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1614000000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
1642000000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1197000000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1114000000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
29000000 usd
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
18000000 usd
CY2022Q3 cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
71000000 usd
CY2021Q3 cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
79000000 usd
CY2022Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-153000000 usd
CY2021Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
2000000 usd
CY2022Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-27000000 usd
CY2021Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-18000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
137000000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
415000000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
25000000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
40000000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
110000000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
369000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
97000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
111000000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
272000000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
110000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
271000000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.94
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
271000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
287000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
273000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
289000000 shares
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4957
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4908
CY2022Q3 us-gaap Profit Loss
ProfitLoss
111000000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
272000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-58000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-25000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-4000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-62000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-27000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
49000000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
245000000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
48000000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
244000000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3492000000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4717000000 usd
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
11039000000 usd
CY2022Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
10561000000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
15891000000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
15636000000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2274000000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2021000000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
32696000000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
32935000000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2339000000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2361000000 usd
CY2022Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
7367000000 usd
CY2022Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
7629000000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
985000000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
953000000 usd
CY2022Q3 us-gaap Assets
Assets
43387000000 usd
CY2022Q2 us-gaap Assets
Assets
43878000000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
28362000000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
27128000000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
578000000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
580000000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2619000000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2842000000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
31559000000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
30550000000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4689000000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4735000000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2576000000 usd
CY2022Q3 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
8919000000 usd
CY2022Q2 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
9299000000 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
755000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
755000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
327000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
327000000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2813000000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-301000000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280000000 usd
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
65000000 shares
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
54000000 shares
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3880000000 usd
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
3128000000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-176000000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-114000000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1781000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-709000000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
1000000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
3000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1780000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-706000000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43387000000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43878000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-706000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
110000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
111000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-62000000 usd
CY2022Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-2000000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11000000 usd
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1000000000 usd
CY2022Q3 us-gaap Dividends
Dividends
131000000 usd
CY2022Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1780000000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1794000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
271000000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
272000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27000000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1000000 usd
CY2021Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
500000000 usd
CY2021Q3 us-gaap Dividends
Dividends
141000000 usd
CY2021Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1396000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
111000000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
272000000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
171000000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
168000000 usd
CY2022Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-153000000 usd
CY2021Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
2000000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10000000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
23000000 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
24000000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29000000 usd
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12000000 usd
CY2022Q3 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
508000000 usd
CY2021Q3 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
214000000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
264000000 usd
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
129000000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1234000000 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-292000000 usd
CY2022Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
926000000 usd
CY2021Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
495000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23000000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-646000000 usd
CY2022Q3 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
CY2021Q3 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
927000000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
70000000 usd
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
67000000 usd
CY2022Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000000 usd
CY2021Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3000000 usd
CY2021Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2000000 usd
CY2022Q3 cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
1000000 usd
CY2021Q3 cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
4000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70000000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
862000000 usd
CY2022Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7000000 usd
CY2021Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
587000000 usd
CY2022Q3 cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
-14000000 usd
CY2021Q3 cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
-28000000 usd
CY2022Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
142000000 usd
CY2021Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
149000000 usd
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1000000000 usd
CY2021Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
500000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1163000000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1264000000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-15000000 usd
CY2021Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5000000 usd
CY2022Q3 cah Cash Reclassified From Assets Held For Sale
CashReclassifiedFromAssetsHeldForSale
0 usd
CY2021Q3 cah Cash Reclassified From Assets Held For Sale
CashReclassifiedFromAssetsHeldForSale
109000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1225000000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-944000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4717000000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3407000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3492000000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2463000000 usd
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
18000000 usd
CY2022Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
5300000000 usd
CY2022Q3 us-gaap Severance Costs1
SeveranceCosts1
19000000 usd
CY2021Q3 us-gaap Severance Costs1
SeveranceCosts1
8000000 usd
CY2022Q3 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
10000000 usd
CY2021Q3 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
10000000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
29000000 usd
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
66000000 usd
CY2022Q3 us-gaap Restructuring Costs
RestructuringCosts
23000000 usd
CY2022Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
21000000 usd
CY2022Q3 us-gaap Restructuring Reserve
RestructuringReserve
68000000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
5855000000 usd
CY2022Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
26000000 usd
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
154000000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
5675000000 usd
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11000000 usd
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4789000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3108000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1681000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P9Y
CY2022Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4800000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3108000000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1692000000 usd
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11000000 usd
CY2022Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11000000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4862000000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3099000000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1763000000 usd
CY2022Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4873000000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3099000000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1774000000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
71000000 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
78000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
212000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
258000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
233000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
206000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
174000000 usd
CY2022Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
5300000000 usd
CY2022Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
28400000000 usd
CY2022Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
27100000000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.007
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.263
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
940000000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
943000000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
858000000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
49000000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
48000000 usd
CY2022Q3 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
CY2022Q3 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
5267000000 usd
CY2022Q2 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
5315000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
7000000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
271000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
287000000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000000 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
273000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
289000000 shares
CY2021Q3 cah Numberofsharesexcludedfromcalculationofdilutedshares
Numberofsharesexcludedfromcalculationofdilutedshares
4000000 shares
CY2022Q3 cah Numberofsharesexcludedfromcalculationofdilutedshares
Numberofsharesexcludedfromcalculationofdilutedshares
4000000 shares
CY2022Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2022Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q3 us-gaap Revenues
Revenues
49603000000 usd
CY2021Q3 us-gaap Revenues
Revenues
43968000000 usd
CY2022Q3 us-gaap Revenues
Revenues
49603000000 usd
CY2021Q3 us-gaap Revenues
Revenues
43968000000 usd
CY2022Q3 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
6000000 usd
CY2021Q3 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
7000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
137000000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
415000000 usd
CY2022Q3 us-gaap Assets
Assets
43387000000 usd
CY2022Q2 us-gaap Assets
Assets
43878000000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23000000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24000000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3000000 usd
CY2021Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4000000 usd

Files In Submission

Name View Source Status
0000721371-22-000133-index-headers.html Edgar Link pending
0000721371-22-000133-index.html Edgar Link pending
0000721371-22-000133.txt Edgar Link pending
0000721371-22-000133-xbrl.zip Edgar Link pending
a23q1_10qx093022xex3113.htm Edgar Link pending
a23q1_10qx093022xex3123.htm Edgar Link pending
a23q1_10qx093022xex3213.htm Edgar Link pending
a23q1_10qx093022xex9911.htm Edgar Link pending
cah-20220930.htm Edgar Link pending
cah-20220930.xsd Edgar Link pending
cah-20220930_g1.jpg Edgar Link pending
cah-20220930_g2.jpg Edgar Link pending
cah-20220930_g3.jpg Edgar Link pending
cah-20220930_g4.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
cah-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cah-20220930_lab.xml Edgar Link unprocessable
cah-20220930_pre.xml Edgar Link unprocessable
cah-20220930_def.xml Edgar Link unprocessable
cah-20220930_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending